Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
xenysalate
- Development stage
- Unknown
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Xenysalate (also known as biphenamine) is a small molecule drug belonging to the class of organic compounds known as biphenyls and derivatives. It has been used primarily in dermatological applications, including medicated shampoos for the treatment of seborrheic scalp disorders. Xenysalate exhibits local anesthetic properties with additional antibacterial and antifungal effects. Its precise molecular mechanism of action remains unclear; however, it is recognized for its antioxidant and anti-inflammatory properties. The compound is experimental and has reached up to Phase II clinical trials[1][2][3][4][5].
- Other names
- biphenaminexenisalatoxenysalatum3572-52-9
Beyond the preview
Go deeper on xenysalate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on xenysalate.